Journal ArticleTransl Stroke Res · December 2024
Cerebral cavernous malformation (CCM), either sporadic or familial, is a devastating vascular malformation affecting the central nervous system that can present with intracerebral hemorrhage, seizure, and new focal neurologic deficits resulting in substant ...
Full textLink to itemCite
Journal ArticleTransl Stroke Res · April 11, 2024
Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating neurologic disease with high mortality and disability. There have been global improvements in survival, which has contributed to the prevalence of patients living with long-term sequelae related to ...
Full textLink to itemCite
Journal ArticleCNS Neurol Disord Drug Targets · 2024
Stroke is a multifactorial vascular disease and remains a leading cause of disability in the United States. Strokes can be ischemic or hemorrhagic in nature and secondary to arterial or venous disease, making determining the etiology and secondary preventi ...
Full textLink to itemCite
Journal ArticleTransl Stroke Res · December 2023
Near-infrared laser therapy, a special form of transcranial light therapy, has been tested as an acute stroke therapy in three large clinical trials. While the NEST trials failed to show the efficacy of light therapy in human stroke patients, there are man ...
Full textLink to itemCite
Journal ArticleCurr Neurol Neurosci Rep · December 2023
PURPOSE OF REVIEW: Stroke remains a leading disabling condition, and many survivors have permanent disability despite acute stroke treatment and subsequent standard-of-care rehabilitation therapies. Adjunctive neuromodulation is an emerging frontier in the ...
Full textLink to itemCite
Journal ArticleNeurorehabil Neural Repair · June 2023
BACKGROUND: Vagus Nerve Stimulation (VNS) paired with rehabilitation improved upper extremity impairment and function in a recent pivotal, randomized, triple-blind, sham-controlled trial in people with chronic arm weakness after stroke. OBJECTIVE: We aimed ...
Full textLink to itemCite
Journal ArticleStroke · May 2023
BACKGROUND: Prior systematic reviews have compared the efficacy of intravenous tenecteplase and alteplase in acute ischemic stroke, assigning their relative complications as a secondary objective. The objective of the present study is to determine whether ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · May 17, 2022
Background Persistent sensorimotor impairments after stroke can negatively impact quality of life. The hippocampus is vulnerable to poststroke secondary degeneration and is involved in sensorimotor behavior but has not been widely studied within the contex ...
Full textLink to itemCite
Journal ArticleJ Am Heart Assoc · February 2022
Background One-quarter of all strokes are subsequent events. It is not known whether higher levels of blood glucose are associated with an increased risk of subsequent stroke after high-risk transient ischemic attack or minor ischemic stroke. Methods and R ...
Full textLink to itemCite
Journal Article · December 21, 2021
AbstractBackgroundMultichannel transcranial electrical stimulation (tES) modeling and optimization have been widely studied in recent years. Its theoretical bases include quasi-static assu ...
Full textCite
Journal ArticleNeurorehabil Neural Repair · August 2021
The effects of low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) on treating poststroke aphasia (PSA) remain inconclusive. We aimed to evaluate the efficacy and safety of LF-rTMS on language function poststroke and determine potential fa ...
Full textOpen AccessLink to itemCite
Journal ArticleStroke · August 2021
BACKGROUND: Central retinal artery occlusion (CRAO) causes sudden, irreversible blindness and is a form of acute ischemic stroke. In this study, we sought to determine the proportion of patients in whom atrial fibrillation (AF) is detected by extended card ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Stroke Cerebrovasc Dis · July 2021
Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke which affects the retina. Intravenous thrombolysis is emerging as a compelling therapeutic approach. However, it is not known which patients may benefit from this therapy because th ...
Full textLink to itemCite
Journal ArticleEur J Neurol · June 2021
BACKGROUND AND PURPOSE: According to evidence-based clinical practice guidelines, patients presenting with disabling stroke symptoms should be treated with intravenous tissue plasminogen activator (IV tPA) within 4.5 h of time last known well. However, 25% ...
Full textLink to itemCite
Journal ArticleLancet (London, England) · April 2021
BackgroundLong-term loss of arm function after ischaemic stroke is common and might be improved by vagus nerve stimulation paired with rehabilitation. We aimed to determine whether this strategy is a safe and effective treatment for improving arm ...
Full textCite
Journal ArticleJMIR Mhealth Uhealth · February 9, 2021
BACKGROUND: To improve the outcomes of acute ischemic stroke (AIS), timely thrombolytic therapy is crucial. Series strategies were recommended to reduce door-to-needle (DTN) time for AIS. Mobile technologies are feasible and have been used in stroke manage ...
Full textLink to itemCite
Journal ArticleSci Rep · January 18, 2021
Stroke is a devastating complication of left ventricular assist device (LVAD) therapy. Understanding the characteristics, risk factors and outcomes of strokes associated with the centrifugal flow LVADs is important to devise better strategies for managemen ...
Full textLink to itemCite
Journal ArticleFront Neurosci · 2021
Background: Although low-intensity transcranial ultrasound stimulation (LI-TUS) has received more recognition for its neuromodulation potential, there remains a crucial knowledge gap regarding the neuromodulatory effects of LI-TUS and its potential for tra ...
Full textLink to itemCite
Journal ArticleFront Neurorobot · 2021
This paper aims to review the current state of brain-to-brain interface (B2BI) technology and its potential. B2BIs function via a brain-computer interface (BCI) to read a sender's brain activity and a computer-brain interface (CBI) to write a pattern to a ...
Full textOpen AccessLink to itemCite
Journal ArticleCurr Med Res Opin · December 2020
BACKGROUND: This study aimed to establish the minimal clinically important difference (MCID) for the Fugl-Meyer Motor Scale (FMMS) and the Disability Rating Scale (DRS) to evaluate interventions in patients with motor deficits in the chronic phase after tr ...
Full textLink to itemCite
Journal Article · November 4, 2020
BACKGROUND To improve the outcomes of acute ischemic stroke (AIS), timely thrombolytic therapy is crucial. Series strategies were recommended to reduce door-to-needle (DTN) time for AIS. ...
Full textCite
Journal ArticleBrain Res · August 15, 2020
The nitric oxide (NO) metabolome and the NO metabolite-based neurovascular protective pathways are dysregulated after stroke. The major NO metabolite S-nitrosoglutahione (GSNO) is essential for S-nitrosylation-based signaling events and the inhibition of S ...
Full textLink to itemCite
Journal ArticleMed Sci Sports Exerc · August 2020
INTRODUCTION: Although exercise is a safe, cost-effective, and therapeutic poststroke therapy, the proper time window and dosage of exercise are still unknown. We aim to determine the optimal combination of time window and intensity of exercise by assessin ...
Full textLink to itemCite
Journal ArticleJ Neuroeng Rehabil · June 15, 2020
BACKGROUND: Non-invasive brain stimulation techniques have been shown in several studies to improve the motor recovery of the affected upper-limbs in stroke patients. This study aims to investigate whether or not cathodal transcranial direct current stimul ...
Full textLink to itemCite
Journal ArticleExp Neurol · June 2020
BACKGROUND: S-Nitrosoglutathione (GSNO) is a nitric oxide donor that has been investigated for neuroprotective and neuro-recovery effect. We aimed to conduct a systematic review on the published literatures using GSNO in both pre-clinical and clinical stro ...
Full textLink to itemCite
Journal ArticleJ Neurosci · May 13, 2020
Despite the success of reperfusion therapy in significantly reducing the extent of infarct expansion after stroke, the effect of revascularization on poststroke neuroinflammation and the role of anti-inflammatory strategies in postreperfusion era are yet t ...
Full textLink to itemCite
Journal ArticleTransl Stroke Res · April 2020
Peripheral sensory stimulation augments post-stroke upper extremity rehabilitation outcomes. Most sensory stimulations interfere with natural hand tasks and the stimulation duration is limited. We developed TheraBracelet, low-level random-frequency vibrati ...
Full textLink to itemCite
Journal ArticleCirc Cardiovasc Qual Outcomes · January 2020
Background Guidelines recommend against the use of intravenous tPA (tissue-type plasminogen activator; IV tPA) in acute ischemic stroke patients with prior ischemic stroke within 3 months. However, there are limited data on the safety of IV tPA in this pop ...
Full textLink to itemCite
Journal ArticleFront Neurol · 2020
Background: Rapid and effective medical care for stroke is paramount to achieve maximal functional recovery. Because of the wide spreading of the coronavirus disease in 2019 (COVID-19), acute stroke care is negatively impacted. How much acute care for stro ...
Full textLink to itemCite
Journal ArticleJ Neurol Sci · August 15, 2019
BACKGROUND: Urinary tract infection (UTI) is one of the most common infections seen in patients hospitalized for acute stroke, resulting in greater utilization of hospital resources in addition to patient discomfort. Although post-stroke infections (PSIs) ...
Full textLink to itemCite
Journal ArticleCell Transplant · December 2018
Exogenous stem cell therapy (SCT) has been recognized recently as a promising neuroregenerative strategy to augment recovery in stroke survivors. Mesenchymal stem cells (MSCs) are the primary source of stem cells used in the majority of both pre-clinical a ...
Full textLink to itemCite
Journal ArticlePM R · September 2018
There has been a renewed research interest in transcranial direct current stimulation (tDCS) as an adjunctive tool for poststroke motor recovery as it has a neuro-modulatory effect on the human cortex. However, there are barriers towards its successful app ...
Full textLink to itemCite
Journal ArticleInt J Stroke · July 2018
Background Several stroke outcome and quality control projects have demonstrated the success in stroke care quality improvement through structured process. However, Chinese health-care systems are challenged with its overwhelming numbers of patients, limit ...
Full textLink to itemCite
Journal ArticleBrain Stimul · 2018
BACKGROUND: Transcranial direct current stimulation (tDCS) is a promising brain modulation technique for several disease conditions. With this technique, some portion of the current penetrates through the scalp to the cortex and modulates cortical excitabi ...
Full textOpen AccessLink to itemCite
Journal ArticleJournal of the neurological sciences · July 2017
BackgroundWith the rapid growth worldwide in cell-phone use, Internet connectivity, and digital health technology, mobile health (mHealth) technology may offer a promising approach to bridge evidence-treatment gaps in stroke prevention. We aimed t ...
Full textCite
Journal ArticleAJNR Am J Neuroradiol · July 2017
BACKGROUND AND PURPOSE: Motor impairment is the most common deficit after stroke. Our aim was to evaluate whether diffusional kurtosis imaging can detect corticospinal tract microstructural changes in the acute phase for patients with first-ever ischemic s ...
Full textLink to itemCite
Journal ArticleBrain stimulation · May 2017
Background and objectiveA prior meta-analysis revealed that higher doses of transcranial direct current stimulation (tDCS) have a better post-stroke upper-extremity motor recovery. While this finding suggests that currents greater than the typical ...
Full textCite
Journal ArticleBrain Stimul · 2016
BACKGROUND AND PURPOSE: Transcranial direct current stimulation (tDCS) has shown mixed results in post-stroke motor recovery, possibly because of tDCS dose differences. The purpose of this meta-analysis was to explore whether the outcome has a dose-respons ...
Full textLink to itemCite
Journal ArticleAnnals of neurology · December 2015
ObjectiveThe aim of this work was to investigate whether an imaging measure of corticospinal tract (CST) injury in the acute phase can predict motor outcome at 3 months in comparison to clinical assessment of initial motor impairment.Methods
Full textCite